Skip to main content
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.


Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Antivirals, Including Antibody Products

These sections summarize data on the use of antiviral agents for the treatment of COVID-19.

Antivirals, Including Antibody Products Summary Recommendations

Recommendations for the use of antiviral agents to treat COVID-19


Information on the use of intravenous remdesivir as treatment for COVID-19

Ritonavir-Boosted Nirmatrelvir (Paxlovid)

Drug interactions and other considerations for the use of ritonavir-boosted nirmatrelvir (Paxlovid)


Information on molnupiravir as an alternative therapy for some nonhospitalized patients with COVID-19

Anti-SARS-CoV-2 Monoclonal Antibodies

Information on monoclonal antibodies that target the SARS-CoV-2 spike protein

COVID-19 Convalescent Plasma

Information on high-titer plasma from donors who have recovered from COVID-19


Information on the use of interferons in patients with COVID-19

Table: Characteristics of Antiviral Agents, Including Antibody Products

Characteristics of antiviral agents evaluated in COVID-19 clinical trials